Review of the risks and benefits of yellow fever vaccination including some new analyses (Q38006992)

26 August 2017

Review of the risks and benefits of yellow fever vaccination including some new analyses (English)

1 reference

26 August 2017

0 references

1 reference

1

Thomas P Monath

1 reference

26 August 2017

1 April 2012

1 reference

Expert Review of Vaccines

26 August 2017

1 reference

26 August 2017

11

1 reference

26 August 2017

4

1 reference

26 August 2017

427-448

1 reference

Epidemiology and ecology of yellow fever virus

26 August 2017

1 reference

Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?

21 January 2018

1 reference

Yellow fever vaccines and international travelers

21 January 2018

1 reference

Treatment of yellow fever

21 January 2018

1 reference

VACCINATION AGAINST YELLOW FEVER WITH IMMUNE SERUM AND VIRUS FIXED FOR MICE.

21 January 2018

1 reference

The use of yellow fever virus modified by in vitro cultivation for human immunization

21 January 2018

1 reference

Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection

21 January 2018

1 reference

Characterization of main cytokine sources from the innate and adaptive immune responses following primary 17DD yellow fever vaccination in adults.

21 January 2018

1 reference

Reactogenicity of yellow fever vaccines in a randomized, placebo-controlled trial

21 January 2018

1 reference

Yellow fever 17D vaccine safety and immunogenicity in the elderly.

21 January 2018

1 reference

Monitoring adverse events following yellow fever vaccination using an integrated telephone and Internet-based system

21 January 2018

1 reference

The monkey safety test for neurovirulence of yellow fever vaccines: the utility of quantitative clinical evaluation and histological examination

21 January 2018

1 reference

Advanced Age a Risk Factor for Illness Temporally Associated with Yellow Fever Vaccination

21 January 2018

1 reference

Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events

21 January 2018

1 reference

Adverse event reports following yellow fever vaccination

21 January 2018

1 reference

Yellow Fever Vaccine Post-marketing Surveillance in Brazil

21 January 2018

1 reference

Short report: Incidence of yellow fever vaccine-associated neurotropic disease

21 January 2018

1 reference

Yellow fever vaccination and increased relapse rate in travelers with multiple sclerosis

21 January 2018

1 reference

Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

21 January 2018

1 reference

Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses

21 January 2018

1 reference

Neurovirulence tests of three 17D yellow fever vaccine strains

21 January 2018

1 reference

Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis

21 January 2018

1 reference

Neuroadapted Yellow Fever Virus 17D: Determinants in the Envelope Protein Govern Neuroinvasiveness for SCID Mice

21 January 2018

1 reference

Attenuation of tick-borne encephalitis virus by structure-based site-specific mutagenesis of a putative flavivirus receptor binding site

21 January 2018

1 reference

Reactions following neurotropic yellow fever vaccine given by scarification in Nigeria

21 January 2018

1 reference

Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases.

21 January 2018

1 reference

Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases

21 January 2018

1 reference

Hepatitis and death following vaccination with 17D-204 yellow fever vaccine

21 January 2018

1 reference

Acute viscerotropic disease following vaccination against yellow fever

21 January 2018

1 reference

Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease

21 January 2018

1 reference

Urban yellow fever epidemic in western Nigeria, 1987.

21 January 2018

1 reference

Case of yellow fever vaccine--associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes

21 January 2018

1 reference

Understanding the role of innate immunity in the mechanism of action of the live attenuated Yellow Fever Vaccine 17D.

21 January 2018

1 reference

History of thymoma and yellow fever vaccination

21 January 2018

1 reference

Viscerotropic disease following yellow fever vaccination in Peru

21 January 2018

1 reference

Immune response during adverse events after 17D-derived yellow fever vaccination in Europe

21 January 2018

1 reference

Positional cloning of the murine flavivirus resistance gene

21 January 2018

1 reference

The Flvr-encoded murine oligoadenylate synthetase 1b (Oas1b) suppresses 2-5A synthesis in intact cells

21 January 2018

1 reference

A Mouse Model for Studying Viscerotropic Disease Caused by Yellow Fever Virus Infection

21 January 2018

1 reference

Genetic Variation in OAS1 Is a Risk Factor for Initial Infection with West Nile Virus in Man

21 January 2018

1 reference

Variability in the 2'-5'-oligoadenylate synthetase gene cluster is associated with human predisposition to tick-borne encephalitis virus-induced disease.

21 January 2018

1 reference

Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection

21 January 2018

1 reference

CCR5 deficiency increases risk of symptomatic West Nile virus infection

21 January 2018

1 reference

Suspected yellow fever vaccine-associated viscerotropic adverse events (1973 and 1978), United States

21 January 2018

1 reference

Yellow fever virus vaccine-associated deaths in young women

21 January 2018

1 reference

Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: systematic review

21 January 2018

1 reference

Safety of the yellow fever vaccine during the September 2001 mass vaccination campaign in Abidjan, Ivory Coast

21 January 2018

1 reference

Vaccine policy changes and epidemiology of poliomyelitis in the United States

21 January 2018

1 reference

Complications of smallpox vaccination, 1968.

21 January 2018

1 reference

Prevention of yellow fever in persons traveling to the tropics

21 January 2018

1 reference

Spanish travelers to high-risk areas in the tropics: airport survey of travel health knowledge, attitudes, and practices in vaccination and malaria prevention

21 January 2018

1 reference

Travel health knowledge, attitudes and practices among United States travelers

21 January 2018

1 reference

Knowledge, attitudes, and practices of Japanese travelers on infectious disease risks and immunization uptake

21 January 2018

1 reference

The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever

21 January 2018

1 reference

Yellow fever vaccination coverage among children in Brazilian capitals

21 January 2018

1 reference

Anamnestic immune response to dengue and decreased severity of yellow fever

21 January 2018

1 reference

Yellow fever in a Brazilian family returning from vacation in an endemic area: relevant clinical features and epidemiological issues

21 January 2018

1 reference

Yellow fever vaccination and pregnancy: a four-year prospective study

21 January 2018

1 reference

Perinatal transmission of yellow fever, Brazil, 2009.

21 January 2018

1 reference

Congenital yellow fever virus infection after immunization in pregnancy

21 January 2018

1 reference

Yellow fever vaccination during pregnancy and spontaneous abortion: a case-control study

21 January 2018

1 reference

The effects of yellow fever immunization (17DD) inadvertently used in early pregnancy during a mass campaign in Brazil

21 January 2018

1 reference

Early exposure to yellow fever vaccine during pregnancy

21 January 2018

1 reference

Case report: probable transmission of vaccine strain of yellow fever virus to an infant via breast milk

21 January 2018

1 reference

Intra-nasal infection of macaques with Yellow Fever (YF) vaccine strain 17D: a novel and economical approach for YF vaccination in man.

21 January 2018

1 reference

Immunogenicity and tolerability of yellow fever vaccination in 23 French HIV-infected patients

21 January 2018

1 reference

Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients

21 January 2018

1 reference

Poor antibody response to yellow fever vaccination in children infected with human immunodeficiency virus type 1.

21 January 2018

1 reference

Detection of yellow fever 17D genome in urine

21 January 2018

1 reference

Factors influencing standard pretravel health advice--a study in Belgium

21 January 2018

1 reference

Why is PTPN22 a good candidate susceptibility gene for autoimmune disease?

21 January 2018

1 reference

Persistence of yellow fever vaccine RNA in urine.

21 January 2018

1 reference

A live, attenuated recombinant West Nile virus vaccine

21 January 2018

1 reference

Persistence of arboviruses and antiviral antibodies in vertebrate hosts: its occurrence and impacts

21 January 2018

1 reference

Persistent Infection with West Nile Virus Years after Initial Infection

21 January 2018

1 reference

Persistent infection and associated nucleotide changes of West Nile virus serially passaged in hamsters

21 January 2018

1 reference

High stability of yellow fever 17D-204 vaccine: a 12-year restrospective analysis of large-scale production.

21 January 2018

1 reference

Fatal yellow fever contracted at the Hospital for Tropical Diseases, London, UK, in 1930.

21 January 2018

1 reference

Reduced intradermal test dose of yellow fever vaccine induces protective immunity in individuals with egg allergy

21 January 2018

1 reference

Anaphylaxis from yellow fever vaccine

21 January 2018

1 reference

Multiple evanescent white dot syndrome following simultaneous hepatitis-A and yellow fever vaccination

21 January 2018

1 reference

Vaccination as a triggering event for autoimmune hepatitis

21 January 2018

1 reference

Herpes zoster after yellow fever vaccination.

21 January 2018

1 reference

WHO Working Group on Technical Specifications for Manufacture and Evaluation of Yellow Fever Vaccines, Geneva, Switzerland, 13–14 May 2009

21 January 2018

1 reference

Low frequency of side effects following an incidental 25 times concentrated dose of yellow fever vaccine

21 January 2018

1 reference

Is it time for a new yellow fever vaccine?

21 January 2018

1 reference

Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model

21 January 2018

1 reference

Inactivated yellow fever 17D vaccine: development and nonclinical safety, immunogenicity and protective activity

21 January 2018

1 reference

Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies

21 January 2018

1 reference

An inactivated cell-culture vaccine against yellow fever

21 January 2018

1 reference

The need for organization and collaboration: establishing a thymoma registry.

21 January 2018

1 reference

Epidemiology and estimated population burden of selected autoimmune diseases in the United States

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.12.6

1 reference

26 August 2017

1 reference

PubMed ID

22551029